Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-02 | Theravance Biopharma, Inc. | Winningham Rick E
(CHIEF EXECUTIVE OFFICER) |
A | Ordinary Shares | A | 300000 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Theravance Biopharma, Inc. | Sawaf Aziz
(SVP & CHIEF FINANCIAL OFFICER) |
A | Ordinary Shares | A | 100000 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Theravance Biopharma, Inc. | Miller Aine
(SVP, DEV & HEAD OF IRE OFFICE) |
A | Ordinary Shares | A | 37500 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Theravance Biopharma, Inc. | Grimaud Brett A.
(SVP, GEN COUNSEL AND SECRETARY) |
A | Ordinary Shares | A | 100000 | $0.00 - $0.00 | $0 |
| 2024-04-02 | Theravance Biopharma, Inc. | Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS) |
A | Ordinary Shares | A | 37500 | $0.00 - $0.00 | $0 |
| 2024-03-15 | Theravance Biopharma, Inc. | Winningham Rick E
(CHIEF EXECUTIVE OFFICER) |
G | Ordinary Shares | D | 14800 | $0.00 - $0.00 | $0 |
| 2024-03-15 | Theravance Biopharma, Inc. | Winningham Rick E
(CHIEF EXECUTIVE OFFICER) |
A | Ordinary Shares | A | 2704 | $8.64 - $8.64 | $23,362 |
| 2024-02-20 | Theravance Biopharma, Inc. | Winningham Rick E
(CHIEF EXECUTIVE OFFICER) |
F | Ordinary Shares | D | 37196 | $8.92 - $8.92 | $331,788 |
| 2024-02-20 | Theravance Biopharma, Inc. | Sawaf Aziz
(SVP & CHIEF FINANCIAL OFFICER) |
F | Ordinary Shares | D | 17036 | $8.92 - $8.92 | $151,961 |
| 2024-02-20 | Theravance Biopharma, Inc. | Miller Aine
(SVP, DEV & HEAD OF IRE OFFICE) |
F | Ordinary Shares | D | 11782 | $8.92 - $8.92 | $105,095 |
| 2024-02-20 | Theravance Biopharma, Inc. | Grimaud Brett A.
(SVP, GEN COUNSEL AND SECRETARY) |
F | Ordinary Shares | D | 17595 | $8.92 - $8.92 | $156,947 |
| 2024-02-20 | Theravance Biopharma, Inc. | GRAHAM RICHARD A
(SVP, RESEARCH & DEVELOPMENT) |
F | Ordinary Shares | D | 19294 | $8.92 - $8.92 | $172,102 |
| 2024-02-22 | Theravance Biopharma, Inc. | Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS) |
S | Ordinary Shares | D | 1254 | $8.71 - $8.71 | $10,922 |
| 2024-02-20 | Theravance Biopharma, Inc. | Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS) |
F | Ordinary Shares | D | 18219 | $8.92 - $8.92 | $162,513 |
| 2023-11-20 | Theravance Biopharma, Inc. | Winningham Rick E
(CHIEF EXECUTIVE OFFICER) |
F | Ordinary Shares | D | 15804 | $10.37 - $10.37 | $163,887 |
| 2023-11-20 | Theravance Biopharma, Inc. | Sawaf Aziz
(SVP & CHIEF FINANCIAL OFFICER) |
F | Ordinary Shares | D | 6187 | $10.37 - $10.37 | $64,159 |
| 2023-11-20 | Theravance Biopharma, Inc. | Grimaud Brett A.
(SVP, GEN COUNSEL AND SECRETARY) |
F | Ordinary Shares | D | 7363 | $10.37 - $10.37 | $76,354 |
| 2023-11-20 | Theravance Biopharma, Inc. | GRAHAM RICHARD A
(SVP, RESEARCH & DEVELOPMENT) |
F | Ordinary Shares | D | 12630 | $10.37 - $10.37 | $130,973 |
| 2023-11-21 | Theravance Biopharma, Inc. | Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS) |
S | Ordinary Shares | D | 1378 | $10.29 - $10.29 | $14,179 |
| 2023-11-20 | Theravance Biopharma, Inc. | Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS) |
F | Ordinary Shares | D | 7982 | $10.37 - $10.37 | $82,773 |
| 2023-11-14 | Theravance Biopharma, Inc. | GRAHAM RICHARD A
(SVP, RESEARCH & DEVELOPMENT) |
S | Ordinary Shares | D | 2482 | $10.22 - $10.22 | $25,366 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |